financetom
Business
financetom
/
Business
/
Jindal Stainless posts Rs 86.5 cr net loss in Q1
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Jindal Stainless posts Rs 86.5 cr net loss in Q1
Sep 8, 2020 8:05 AM

Jindal Stainless Ltd (JSL) on Tuesday posted a net loss of Rs 86.50 crore during the quarter ended June 30, mainly on account of reduced income. The company had reported a net profit of Rs 66.83 crore during the same quarter a year ago, JSL said in a BSE filing.

During April-June, the company’s total income plunged to Rs 1,271.75 crore from Rs 3,076.43 crore in the year-ago quarter. Total expenses during the period under review stood at Rs 1,410.04 crore as against Rs 2,995.61 crore a year ago.

JSL recorded a loss primarily on account of COVID-19 pandemic-induced business environment, it said in a statement. With the gradual easing of nationwide lockdown in May-June, JSL’s operations have been inching towards normalcy, it said.

”Domestic stainless steel industry was no exception to the slowdown caused by COVID-19. For JSL too, it was an unprecedented quarter, with operations completely suspended in April,” JSL Managing Director Abhyuday Jindal was quoted as saying in the statement. The company has undertaken several business, operational, and strategic initiatives to minimise the impact of the pandemic, and hopes to recover by the end of September with improved business sentiments, he added.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved